Comparison of the efficacy and tolerability of tigecycline and imipenem/cilastatin in patients with nosocomial pneumonia.
Phase of Trial: Phase III
Latest Information Update: 14 Jan 2011
At a glance
- Drugs Imipenem/cilastatin; Tigecycline
- Indications Nosocomial pneumonia; Staphylococcal infections
- Focus Therapeutic Use
- 14 Jan 2011 New trial record
- 22 Jun 2009 Primary endpoint 'Clinical-response-rate' has not been met in the clinically-evaluable population but was met in the clinically-modified intention-to-treat population.